Navigation Links
Genetic Research Sheds Light on Adrenal Gland Tumor Risk
Date:12/14/2010

TUESDAY, Dec. 14 (HealthDay News) -- Scientists report that they have advanced their knowledge of genetic mutations associated with adrenal gland tumors by identifying 13 new potential variations.

Tumors called pheochromocytomas can affect the adrenal gland, which is located above the kidney. These tumors -- which are usually benign but can also be cancerous -- cause the adrenal gland to produce too much adrenaline, resulting in high blood pressure, headaches, heart palpitations, nausea and vomiting.

In the new study, which included nearly 1,000 people, the researchers identified 19 mutations in the FP/TMEM127 gene that may be associated with pheochromocytomas in the adrenal gland.

"Of these, 19 mutations found in 20 patients were considered of potential pathogenic significance. Thirteen of these variants were [new], while the remainder had been previously reported," Li Yao, of the University of Texas Health Science Center at San Antonio, and colleagues wrote in the report published in the Dec. 15 issue of the Journal of the American Medical Association.

The average age of patients when they developed FP/TMEM127-mutated tumors was 42.8 years and median (midpoint) age was 41.5 years.

"These observations support the existence of additional pheochromocytoma susceptibility genes, which may account for some of the genetically undefined cases," the authors wrote in a news release from the journal's publisher.

More information

The American Urological Association has more about pheochromocytoma.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, Dec. 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Rare Genetic Syndrome May Increase Colon Cancer Risk
2. Chinese Study Suggests New Way to Test for Genetic Diseases
3. New discovery prevents symptoms of rare genetic disorder
4. Genetic mutations associated with increased PSA and prostate cancer
5. Novel genetic mutation that causes the most common form of eye cancer discovered
6. Rare, Severe Form of Morning Sickness Appears to Be Genetic
7. Our normal genetics may influence cancer growth, too
8. Academies of science call for amendments to impracticable Genetic Diagnostics Act
9. New research shows genetic test for lung cancer risk prompts smokers to quit
10. Genetic Deletion Linked to Raised Risk of Autism, Schizophrenia
11. ASHG 2010: New research on implications of direct-to-consumer and clinical genetic testing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Research Sheds Light on Adrenal Gland Tumor Risk
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: